Key facts
- VANGUARD GROUP INC filed SCHEDULE 13G for CytoSorbents Corp Common Stock (CTSO).
- Disclosed ownership: 7.1%.
- Date of event: 31 Dec 2024.
VANGUARD GROUP INC - 31 Dec 2024 SCHEDULE 13G Report for CytoSorbents Corp Common Stock (CTSO)
- Filing Manager
- VANGUARD GROUP INC
- Reporting Manager
- The Vanguard Group
- Security
- CytoSorbents Corp Common Stock
- Symbol
- CTSO
- Shares outstanding
- 54,685,863 shares
- Disclosed Ownership
- 3,899,102 shares
- Ownership
- 7.1%
- Form type
- SCHEDULE 13G
- Filing time
- 31 Jan 2025, 18:49:36 UTC
- Date of event
- 31 Dec 2024
- Next filing
- 30 Apr 2025
- SEC
- View on sec.gov
Key filing fact
VANGUARD GROUP INC disclosed 7.1% ownership in CytoSorbents Corp Common Stock (CTSO) on 31 Dec 2024.
Change
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 31 Jan 2025, 18:49.
Research use
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Reporting managers (1)
Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| The Vanguard Group | 7.1% | 3,899,102 | 0 | 0 | Ashley Grim | Head of Global Fund Administration |
CIK / CUSIP context first